Rite Aid Corp
NYSE:RAD
Rite Aid Corp
NYSE:RAD
Price:
0.1728 USD
-4.95%
Market Closed
Updated:
May 8, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
11.4
Current
10.4
Median
8.4
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=11.4
Enterprise Value
/
3.2B
EBITDA
282.9m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Rite Aid Corp
NYSE:RAD
|
9.8m USD | 11.4 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
73B Zac | 0 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.2B Zac | 0 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15B USD | 5.2 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
44.8B BRL | 12.9 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.5B CNY | 22.1 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
945.8B JPY | 9.3 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.8B SAR | 11.3 | |
| MX |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
79.4B MXN | 8.1 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
596.8B JPY | 11.7 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.3B CNY | 15 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A
You don't have any saved screeners yet
